Histone variants and melanoma

facts and hypotheses

Nikifor K. Konstantinov, Constance J. Ulff-Møller, Stefan Dimitrov

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Melanoma is the most aggressive form of skin cancer with rising incidence and morbidity. Despite advances in treatment, the 10-yr survival for patients with metastatic disease is less than 10%. During the past few years, ongoing research on different epigenomic aberrations in melanoma has catalyzed better understanding of its pathogenesis and identification of new therapeutics. In our review, we will focus on the role of histone variants, key epigenetic players in melanoma initiation and progression. Specifically, incorporation of histone variants enables additional layers of chromatin structure, and here, we will describe how alterations in this epigenetic behavior impact melanoma.

Original languageEnglish
Pages (from-to)426-433
Number of pages8
JournalPigment Cell and Melanoma Research
Volume29
Issue number4
DOIs
Publication statusPublished - 1 Jul 2016
Externally publishedYes

Fingerprint

Histones
Melanoma
Epigenomics
Aberrations
Chromatin
Skin
Skin Neoplasms
Morbidity
Survival
Incidence
Therapeutics
Research

Keywords

  • epigenetics
  • H3.3
  • histone variants
  • macroH2A
  • melanoma

ASJC Scopus subject areas

  • Oncology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Dermatology

Cite this

Histone variants and melanoma : facts and hypotheses. / Konstantinov, Nikifor K.; Ulff-Møller, Constance J.; Dimitrov, Stefan.

In: Pigment Cell and Melanoma Research, Vol. 29, No. 4, 01.07.2016, p. 426-433.

Research output: Contribution to journalReview article

Konstantinov, Nikifor K. ; Ulff-Møller, Constance J. ; Dimitrov, Stefan. / Histone variants and melanoma : facts and hypotheses. In: Pigment Cell and Melanoma Research. 2016 ; Vol. 29, No. 4. pp. 426-433.
@article{d9415a7f30dd44469236f7342e7f4086,
title = "Histone variants and melanoma: facts and hypotheses",
abstract = "Melanoma is the most aggressive form of skin cancer with rising incidence and morbidity. Despite advances in treatment, the 10-yr survival for patients with metastatic disease is less than 10{\%}. During the past few years, ongoing research on different epigenomic aberrations in melanoma has catalyzed better understanding of its pathogenesis and identification of new therapeutics. In our review, we will focus on the role of histone variants, key epigenetic players in melanoma initiation and progression. Specifically, incorporation of histone variants enables additional layers of chromatin structure, and here, we will describe how alterations in this epigenetic behavior impact melanoma.",
keywords = "epigenetics, H3.3, histone variants, macroH2A, melanoma",
author = "Konstantinov, {Nikifor K.} and Ulff-M{\o}ller, {Constance J.} and Stefan Dimitrov",
year = "2016",
month = "7",
day = "1",
doi = "10.1111/pcmr.12467",
language = "English",
volume = "29",
pages = "426--433",
journal = "Pigment Cell and Melanoma Research",
issn = "1755-1471",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Histone variants and melanoma

T2 - facts and hypotheses

AU - Konstantinov, Nikifor K.

AU - Ulff-Møller, Constance J.

AU - Dimitrov, Stefan

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Melanoma is the most aggressive form of skin cancer with rising incidence and morbidity. Despite advances in treatment, the 10-yr survival for patients with metastatic disease is less than 10%. During the past few years, ongoing research on different epigenomic aberrations in melanoma has catalyzed better understanding of its pathogenesis and identification of new therapeutics. In our review, we will focus on the role of histone variants, key epigenetic players in melanoma initiation and progression. Specifically, incorporation of histone variants enables additional layers of chromatin structure, and here, we will describe how alterations in this epigenetic behavior impact melanoma.

AB - Melanoma is the most aggressive form of skin cancer with rising incidence and morbidity. Despite advances in treatment, the 10-yr survival for patients with metastatic disease is less than 10%. During the past few years, ongoing research on different epigenomic aberrations in melanoma has catalyzed better understanding of its pathogenesis and identification of new therapeutics. In our review, we will focus on the role of histone variants, key epigenetic players in melanoma initiation and progression. Specifically, incorporation of histone variants enables additional layers of chromatin structure, and here, we will describe how alterations in this epigenetic behavior impact melanoma.

KW - epigenetics

KW - H3.3

KW - histone variants

KW - macroH2A

KW - melanoma

UR - http://www.scopus.com/inward/record.url?scp=84975702121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975702121&partnerID=8YFLogxK

U2 - 10.1111/pcmr.12467

DO - 10.1111/pcmr.12467

M3 - Review article

VL - 29

SP - 426

EP - 433

JO - Pigment Cell and Melanoma Research

JF - Pigment Cell and Melanoma Research

SN - 1755-1471

IS - 4

ER -